SlideShare a Scribd company logo
1 of 22
FDA requested recall
&
Firm's initiative recall
Recall:
A recall is defined as the removal of a marketed
product because of design or production defects
that may compromise safety, efficacy and purity
of the product or because of government
regulation.
When are Drugs Recalled?
 A recall occurs when a drug manufacturer or the
FDA decides that a pharmaceutical drug is not safe
and should be removed from the market.
 Sometimes a recall is necessary because new
research shows that the drug is too dangerous for use
by consumers.
This could be because of any of the following:
1.The drug causes dangerous side effects.
2.The FDA has discovered a safer alternative to the drug.
3.Consumers use the drug improperly and that unauthorized
use causes serious injury or death.
4.Manufacturing error or contamination incident makes a
particular batch of the drug unsafe.
5. Defective based on stability study, market complaints.
Product Recall:
Product recalls are actions taken by a firm to
remove a product from the market.
Recalls may be conducted on the basis of:
By FDA requested recall
By a Firm's own initiative recall
 The FDA recall class schedule uses "1" as the
most dangerous and "3" as the least dangerous.
 The severity of the recall is less as the number
increases.
FDA requested recall:
The FDA is responsible for making sure that
products like drugs, vaccines, and medical
devices are safe and effective.
FDA informs the manufacturer that its product is
defective and suggests or requests that the
manufacturer recall the drug.
 These recalls are often highly publicized in
newspapers and on radio and TV news broadcasts.
 The FDA has no authority under the Federal Food,
Drug and Cosmetic Act to order a recall.
 The FDA does have the authority to ask a company
to recall a particular product.
FDA has jurisdiction over food, drugs, cosmetics,
medical devices and other products and serves as
a monitor over product recalls.
In most cases, recalls are done voluntarily by the
manufacturer or the distributor of the product.
 In some cases, a company will discover that one of
its products is defective and will recall it.
 In others cases, the FDA will notify a company that
one of its products is defective and will suggest or
request a recall.
 Usually, the company will comply; if it does not, the
FDA can seek a court order authorizing the Federal
Government to seize the product.
 The FDA guidelines categorize all recalls into one of
three classes according to the level of hazard
involved.
 Class I recalls are for dangerous or defective
products that predictably could cause serious health
problems or death.
 Examples of products that could fall into this
category are a food found to contain toxin, a label
mix-up on a lifesaving drug, or a defective artificial
heart valve.
 Class II recalls are for products that might cause
a temporary health problem, or pose only a slight
threat of a serious nature.
 One example is a drug that is under- strength, but
that is not used to treat life-threatening situations.
 Class III recalls are for products that are
unlikely to cause any adverse health reaction, but
that violates FDA regulations.
 An example might be bottles of aspirin that
contains 90 tablets instead of the 100 stated on
the label.
 FDA will check on a company's performance in
recalling the product:
 For a Class I recall, for example, the FDA would
check to make sure that each defective product
has been recalled or reconditioned.
 In contrast, for a Class II and class III recalls the
FDA may decide that it only needs to spot check to
make sure the product is off the market.
Firm's own initiative (choice) recall:
 Firm's own initiative recall is also known as the
manufacturer initiates the recall. This is the most
common method of recall.
A Manufacturer initiates the recall for:
 Class I recall: a situation in which there is a reasonable
probability that the use of or exposure to a violative
product will cause serious adverse health consequences
or death.
 Class II recalls are for products that might cause a
temporary health problem, or pose only a slight threat of
a serious nature.
 One example is a drug that is under- strength, but that is
not used to treat life-threatening situations.
 Class III recalls are for products that are unlikely to
cause any adverse health reaction, but that violates FDA
regulations.
 An example might be bottles of aspirin that contains 90
tablets instead of the 100 stated on the label.
Some Examples of drug recalls include:
 McNeil Consumer Healthcare's April 2010 recall of
certain batches of over-the-counter children's drugs,
including liquid Tylenol, Motrin, and Zyrtec because of
possible contaminants.
 The 2008 recall of Baxter Healthcare's anticoagulant
drug, heparin, because the FDA found contaminants in
the drug that caused severe injury and death in some
people.
 When a manufacturer initiates a drug recall, it must notify
the FDA, submit progress reports on the recall, and follow
up to make sure the recall was successful.
 The FDA publishes guidelines for manufacturers to follow
when recalling drugs.
 These are found in Title 21 of the Code of Federal
Regulations, Part 7.
 i.e 21 CFR Part 7
Notice of Recalls:
There are several ways that the manufacturer and the FDA
notify consumers about a recall.
1.Direct notification.
 The drug manufacturer must notify its direct accounts
(such as wholesalers or chain drug stores) about the recall.
2.Public notification.
The FDA maintains a list of drug and medical device recalls
on its website (www.fda.gov) called Recalls, Market
Withdrawals, & Safety Alerts.
3.Media coverage:
Often, if a drug recall affects many people, or the recalled
drug causes severe injury or death, the media will report
on the recall.
FDA requested recall & Firm's initiative recall

More Related Content

What's hot

Labeling in india
Labeling in indiaLabeling in india
Labeling in india
bdvfgbdhg
 

What's hot (20)

Federal Regulatory Issues Us Food And Drug Administration Medical Device Amen...
Federal Regulatory Issues Us Food And Drug Administration Medical Device Amen...Federal Regulatory Issues Us Food And Drug Administration Medical Device Amen...
Federal Regulatory Issues Us Food And Drug Administration Medical Device Amen...
 
Pharmaceutical labelling
Pharmaceutical labellingPharmaceutical labelling
Pharmaceutical labelling
 
Generic drug ppt
Generic drug pptGeneric drug ppt
Generic drug ppt
 
Important questions of Semester 5 according to PCI syllabus
Important questions of Semester 5 according to PCI syllabusImportant questions of Semester 5 according to PCI syllabus
Important questions of Semester 5 according to PCI syllabus
 
Labeling of Drugs: 21 CFR Part 201
Labeling of Drugs: 21 CFR Part 201 Labeling of Drugs: 21 CFR Part 201
Labeling of Drugs: 21 CFR Part 201
 
Bioavailability ppt
Bioavailability pptBioavailability ppt
Bioavailability ppt
 
Generic drug development
Generic drug developmentGeneric drug development
Generic drug development
 
Gc appli
Gc appliGc appli
Gc appli
 
AzCI presents: Medical Device Regulations through the FDA
AzCI presents: Medical Device Regulations through the FDAAzCI presents: Medical Device Regulations through the FDA
AzCI presents: Medical Device Regulations through the FDA
 
Labeling in india
Labeling in indiaLabeling in india
Labeling in india
 
Qui Tam: Off Label Drug Marketing [Data Snapshot]
Qui Tam: Off Label Drug Marketing [Data Snapshot]Qui Tam: Off Label Drug Marketing [Data Snapshot]
Qui Tam: Off Label Drug Marketing [Data Snapshot]
 
Finding and evaluating branded and generic market entry opportunities
Finding and evaluating branded and generic market entry opportunitiesFinding and evaluating branded and generic market entry opportunities
Finding and evaluating branded and generic market entry opportunities
 
Labelling of pharmaceutical products
Labelling of pharmaceutical productsLabelling of pharmaceutical products
Labelling of pharmaceutical products
 
Hatch waxman act
Hatch waxman actHatch waxman act
Hatch waxman act
 
"Scientific Exchange -- New Interpretations??"
"Scientific Exchange -- New Interpretations??""Scientific Exchange -- New Interpretations??"
"Scientific Exchange -- New Interpretations??"
 
Ich quality guidelines
Ich quality guidelinesIch quality guidelines
Ich quality guidelines
 
Pharmacists Licensure Exam Modules
Pharmacists Licensure Exam ModulesPharmacists Licensure Exam Modules
Pharmacists Licensure Exam Modules
 
The UK (MHRA) approach to combating Falsified Medicines by Gerald Heddell, MHRA
The UK (MHRA) approach to combating Falsified Medicines by Gerald Heddell, MHRAThe UK (MHRA) approach to combating Falsified Medicines by Gerald Heddell, MHRA
The UK (MHRA) approach to combating Falsified Medicines by Gerald Heddell, MHRA
 
WHO model list of essential medicines: 21st list 2019
WHO model list of essential medicines: 21st list 2019WHO model list of essential medicines: 21st list 2019
WHO model list of essential medicines: 21st list 2019
 
The hatch waxman act
The hatch waxman actThe hatch waxman act
The hatch waxman act
 

Similar to FDA requested recall & Firm's initiative recall

Eugene D. Fanning Center for Business Communication 01-01Men.docx
Eugene D. Fanning Center for Business Communication 01-01Men.docxEugene D. Fanning Center for Business Communication 01-01Men.docx
Eugene D. Fanning Center for Business Communication 01-01Men.docx
humphrieskalyn
 
Federal food, drug & cosmetics act
Federal food, drug & cosmetics actFederal food, drug & cosmetics act
Federal food, drug & cosmetics act
Jamia Hamdard
 
History of Drug Aproval
History of Drug AprovalHistory of Drug Aproval
History of Drug Aproval
dbwalton
 

Similar to FDA requested recall & Firm's initiative recall (20)

Recall of ph product
Recall of ph productRecall of ph product
Recall of ph product
 
Food Recall Readiness - Is Your Plan In Place?
Food Recall Readiness - Is Your Plan In Place?Food Recall Readiness - Is Your Plan In Place?
Food Recall Readiness - Is Your Plan In Place?
 
FDA
FDAFDA
FDA
 
Eugene D. Fanning Center for Business Communication 01-01Men.docx
Eugene D. Fanning Center for Business Communication 01-01Men.docxEugene D. Fanning Center for Business Communication 01-01Men.docx
Eugene D. Fanning Center for Business Communication 01-01Men.docx
 
Product recall overview
Product recall overviewProduct recall overview
Product recall overview
 
Pharmaceutical product recall
Pharmaceutical product recallPharmaceutical product recall
Pharmaceutical product recall
 
handling of pharmaceutical product recall
handling of pharmaceutical product recallhandling of pharmaceutical product recall
handling of pharmaceutical product recall
 
ANDA FDA APPLICATION
ANDA FDA APPLICATIONANDA FDA APPLICATION
ANDA FDA APPLICATION
 
FDA Approved vs FDA Cleared
FDA Approved vs FDA ClearedFDA Approved vs FDA Cleared
FDA Approved vs FDA Cleared
 
Recalls: The First Smoke of A Mass Tort -- Overview of a Recall of an FDA-Reg...
Recalls: The First Smoke of A Mass Tort -- Overview of a Recall of an FDA-Reg...Recalls: The First Smoke of A Mass Tort -- Overview of a Recall of an FDA-Reg...
Recalls: The First Smoke of A Mass Tort -- Overview of a Recall of an FDA-Reg...
 
What is FDA?
What is FDA?What is FDA?
What is FDA?
 
COVID-19 and the FDA: What Every Manufacturing Company Needs to Know
COVID-19 and the FDA: What Every Manufacturing Company Needs to KnowCOVID-19 and the FDA: What Every Manufacturing Company Needs to Know
COVID-19 and the FDA: What Every Manufacturing Company Needs to Know
 
Health Canada Progressive Licensing - Professor Peivand Pirouzi
Health Canada Progressive Licensing - Professor Peivand PirouziHealth Canada Progressive Licensing - Professor Peivand Pirouzi
Health Canada Progressive Licensing - Professor Peivand Pirouzi
 
Importing medical devices
Importing medical devicesImporting medical devices
Importing medical devices
 
guide.pdf
guide.pdfguide.pdf
guide.pdf
 
Inside the FDA
Inside the FDAInside the FDA
Inside the FDA
 
USFDA GUIDLINES
USFDA GUIDLINESUSFDA GUIDLINES
USFDA GUIDLINES
 
Federal food, drug & cosmetics act
Federal food, drug & cosmetics actFederal food, drug & cosmetics act
Federal food, drug & cosmetics act
 
Fda gmp compliance for the Life Science Industry
Fda gmp compliance for the Life Science IndustryFda gmp compliance for the Life Science Industry
Fda gmp compliance for the Life Science Industry
 
History of Drug Aproval
History of Drug AprovalHistory of Drug Aproval
History of Drug Aproval
 

More from AshishVerma593 (9)

Vacuum still
Vacuum stillVacuum still
Vacuum still
 
Vaccum dryer
Vaccum dryerVaccum dryer
Vaccum dryer
 
Vacuum distillation
Vacuum distillationVacuum distillation
Vacuum distillation
 
Silverson mixer
Silverson mixerSilverson mixer
Silverson mixer
 
Freeze drying
Freeze dryingFreeze drying
Freeze drying
 
21 Code of Federal Regulation(21-CFR)
21 Code of Federal Regulation(21-CFR)21 Code of Federal Regulation(21-CFR)
21 Code of Federal Regulation(21-CFR)
 
Recall termination
Recall terminationRecall termination
Recall termination
 
Pharmaceuticals Recall status report
Pharmaceuticals Recall status reportPharmaceuticals Recall status report
Pharmaceuticals Recall status report
 
Pharmaceuticals Sampling plans and techniques
Pharmaceuticals Sampling plans and techniquesPharmaceuticals Sampling plans and techniques
Pharmaceuticals Sampling plans and techniques
 

Recently uploaded

Spellings Wk 3 English CAPS CARES Please Practise
Spellings Wk 3 English CAPS CARES Please PractiseSpellings Wk 3 English CAPS CARES Please Practise
Spellings Wk 3 English CAPS CARES Please Practise
AnaAcapella
 

Recently uploaded (20)

SOC 101 Demonstration of Learning Presentation
SOC 101 Demonstration of Learning PresentationSOC 101 Demonstration of Learning Presentation
SOC 101 Demonstration of Learning Presentation
 
HMCS Max Bernays Pre-Deployment Brief (May 2024).pptx
HMCS Max Bernays Pre-Deployment Brief (May 2024).pptxHMCS Max Bernays Pre-Deployment Brief (May 2024).pptx
HMCS Max Bernays Pre-Deployment Brief (May 2024).pptx
 
Spellings Wk 3 English CAPS CARES Please Practise
Spellings Wk 3 English CAPS CARES Please PractiseSpellings Wk 3 English CAPS CARES Please Practise
Spellings Wk 3 English CAPS CARES Please Practise
 
REMIFENTANIL: An Ultra short acting opioid.pptx
REMIFENTANIL: An Ultra short acting opioid.pptxREMIFENTANIL: An Ultra short acting opioid.pptx
REMIFENTANIL: An Ultra short acting opioid.pptx
 
Spatium Project Simulation student brief
Spatium Project Simulation student briefSpatium Project Simulation student brief
Spatium Project Simulation student brief
 
How to setup Pycharm environment for Odoo 17.pptx
How to setup Pycharm environment for Odoo 17.pptxHow to setup Pycharm environment for Odoo 17.pptx
How to setup Pycharm environment for Odoo 17.pptx
 
2024-NATIONAL-LEARNING-CAMP-AND-OTHER.pptx
2024-NATIONAL-LEARNING-CAMP-AND-OTHER.pptx2024-NATIONAL-LEARNING-CAMP-AND-OTHER.pptx
2024-NATIONAL-LEARNING-CAMP-AND-OTHER.pptx
 
Beyond_Borders_Understanding_Anime_and_Manga_Fandom_A_Comprehensive_Audience_...
Beyond_Borders_Understanding_Anime_and_Manga_Fandom_A_Comprehensive_Audience_...Beyond_Borders_Understanding_Anime_and_Manga_Fandom_A_Comprehensive_Audience_...
Beyond_Borders_Understanding_Anime_and_Manga_Fandom_A_Comprehensive_Audience_...
 
FSB Advising Checklist - Orientation 2024
FSB Advising Checklist - Orientation 2024FSB Advising Checklist - Orientation 2024
FSB Advising Checklist - Orientation 2024
 
General Principles of Intellectual Property: Concepts of Intellectual Proper...
General Principles of Intellectual Property: Concepts of Intellectual  Proper...General Principles of Intellectual Property: Concepts of Intellectual  Proper...
General Principles of Intellectual Property: Concepts of Intellectual Proper...
 
Application orientated numerical on hev.ppt
Application orientated numerical on hev.pptApplication orientated numerical on hev.ppt
Application orientated numerical on hev.ppt
 
Unit-V; Pricing (Pharma Marketing Management).pptx
Unit-V; Pricing (Pharma Marketing Management).pptxUnit-V; Pricing (Pharma Marketing Management).pptx
Unit-V; Pricing (Pharma Marketing Management).pptx
 
Micro-Scholarship, What it is, How can it help me.pdf
Micro-Scholarship, What it is, How can it help me.pdfMicro-Scholarship, What it is, How can it help me.pdf
Micro-Scholarship, What it is, How can it help me.pdf
 
Jamworks pilot and AI at Jisc (20/03/2024)
Jamworks pilot and AI at Jisc (20/03/2024)Jamworks pilot and AI at Jisc (20/03/2024)
Jamworks pilot and AI at Jisc (20/03/2024)
 
How to Manage Global Discount in Odoo 17 POS
How to Manage Global Discount in Odoo 17 POSHow to Manage Global Discount in Odoo 17 POS
How to Manage Global Discount in Odoo 17 POS
 
On National Teacher Day, meet the 2024-25 Kenan Fellows
On National Teacher Day, meet the 2024-25 Kenan FellowsOn National Teacher Day, meet the 2024-25 Kenan Fellows
On National Teacher Day, meet the 2024-25 Kenan Fellows
 
TỔNG ÔN TẬP THI VÀO LỚP 10 MÔN TIẾNG ANH NĂM HỌC 2023 - 2024 CÓ ĐÁP ÁN (NGỮ Â...
TỔNG ÔN TẬP THI VÀO LỚP 10 MÔN TIẾNG ANH NĂM HỌC 2023 - 2024 CÓ ĐÁP ÁN (NGỮ Â...TỔNG ÔN TẬP THI VÀO LỚP 10 MÔN TIẾNG ANH NĂM HỌC 2023 - 2024 CÓ ĐÁP ÁN (NGỮ Â...
TỔNG ÔN TẬP THI VÀO LỚP 10 MÔN TIẾNG ANH NĂM HỌC 2023 - 2024 CÓ ĐÁP ÁN (NGỮ Â...
 
Unit 3 Emotional Intelligence and Spiritual Intelligence.pdf
Unit 3 Emotional Intelligence and Spiritual Intelligence.pdfUnit 3 Emotional Intelligence and Spiritual Intelligence.pdf
Unit 3 Emotional Intelligence and Spiritual Intelligence.pdf
 
HMCS Vancouver Pre-Deployment Brief - May 2024 (Web Version).pptx
HMCS Vancouver Pre-Deployment Brief - May 2024 (Web Version).pptxHMCS Vancouver Pre-Deployment Brief - May 2024 (Web Version).pptx
HMCS Vancouver Pre-Deployment Brief - May 2024 (Web Version).pptx
 
Basic Civil Engineering first year Notes- Chapter 4 Building.pptx
Basic Civil Engineering first year Notes- Chapter 4 Building.pptxBasic Civil Engineering first year Notes- Chapter 4 Building.pptx
Basic Civil Engineering first year Notes- Chapter 4 Building.pptx
 

FDA requested recall & Firm's initiative recall

  • 1. FDA requested recall & Firm's initiative recall
  • 2. Recall: A recall is defined as the removal of a marketed product because of design or production defects that may compromise safety, efficacy and purity of the product or because of government regulation.
  • 3. When are Drugs Recalled?  A recall occurs when a drug manufacturer or the FDA decides that a pharmaceutical drug is not safe and should be removed from the market.  Sometimes a recall is necessary because new research shows that the drug is too dangerous for use by consumers.
  • 4. This could be because of any of the following: 1.The drug causes dangerous side effects. 2.The FDA has discovered a safer alternative to the drug. 3.Consumers use the drug improperly and that unauthorized use causes serious injury or death. 4.Manufacturing error or contamination incident makes a particular batch of the drug unsafe. 5. Defective based on stability study, market complaints.
  • 5. Product Recall: Product recalls are actions taken by a firm to remove a product from the market. Recalls may be conducted on the basis of: By FDA requested recall By a Firm's own initiative recall
  • 6.  The FDA recall class schedule uses "1" as the most dangerous and "3" as the least dangerous.  The severity of the recall is less as the number increases.
  • 7. FDA requested recall: The FDA is responsible for making sure that products like drugs, vaccines, and medical devices are safe and effective. FDA informs the manufacturer that its product is defective and suggests or requests that the manufacturer recall the drug.
  • 8.  These recalls are often highly publicized in newspapers and on radio and TV news broadcasts.  The FDA has no authority under the Federal Food, Drug and Cosmetic Act to order a recall.  The FDA does have the authority to ask a company to recall a particular product.
  • 9. FDA has jurisdiction over food, drugs, cosmetics, medical devices and other products and serves as a monitor over product recalls. In most cases, recalls are done voluntarily by the manufacturer or the distributor of the product.
  • 10.  In some cases, a company will discover that one of its products is defective and will recall it.  In others cases, the FDA will notify a company that one of its products is defective and will suggest or request a recall.  Usually, the company will comply; if it does not, the FDA can seek a court order authorizing the Federal Government to seize the product.
  • 11.  The FDA guidelines categorize all recalls into one of three classes according to the level of hazard involved.  Class I recalls are for dangerous or defective products that predictably could cause serious health problems or death.  Examples of products that could fall into this category are a food found to contain toxin, a label mix-up on a lifesaving drug, or a defective artificial heart valve.
  • 12.  Class II recalls are for products that might cause a temporary health problem, or pose only a slight threat of a serious nature.  One example is a drug that is under- strength, but that is not used to treat life-threatening situations.
  • 13.  Class III recalls are for products that are unlikely to cause any adverse health reaction, but that violates FDA regulations.  An example might be bottles of aspirin that contains 90 tablets instead of the 100 stated on the label.
  • 14.  FDA will check on a company's performance in recalling the product:  For a Class I recall, for example, the FDA would check to make sure that each defective product has been recalled or reconditioned.  In contrast, for a Class II and class III recalls the FDA may decide that it only needs to spot check to make sure the product is off the market.
  • 15. Firm's own initiative (choice) recall:  Firm's own initiative recall is also known as the manufacturer initiates the recall. This is the most common method of recall. A Manufacturer initiates the recall for:  Class I recall: a situation in which there is a reasonable probability that the use of or exposure to a violative product will cause serious adverse health consequences or death.
  • 16.  Class II recalls are for products that might cause a temporary health problem, or pose only a slight threat of a serious nature.  One example is a drug that is under- strength, but that is not used to treat life-threatening situations.
  • 17.  Class III recalls are for products that are unlikely to cause any adverse health reaction, but that violates FDA regulations.  An example might be bottles of aspirin that contains 90 tablets instead of the 100 stated on the label.
  • 18. Some Examples of drug recalls include:  McNeil Consumer Healthcare's April 2010 recall of certain batches of over-the-counter children's drugs, including liquid Tylenol, Motrin, and Zyrtec because of possible contaminants.  The 2008 recall of Baxter Healthcare's anticoagulant drug, heparin, because the FDA found contaminants in the drug that caused severe injury and death in some people.
  • 19.  When a manufacturer initiates a drug recall, it must notify the FDA, submit progress reports on the recall, and follow up to make sure the recall was successful.  The FDA publishes guidelines for manufacturers to follow when recalling drugs.  These are found in Title 21 of the Code of Federal Regulations, Part 7.  i.e 21 CFR Part 7
  • 20. Notice of Recalls: There are several ways that the manufacturer and the FDA notify consumers about a recall. 1.Direct notification.  The drug manufacturer must notify its direct accounts (such as wholesalers or chain drug stores) about the recall.
  • 21. 2.Public notification. The FDA maintains a list of drug and medical device recalls on its website (www.fda.gov) called Recalls, Market Withdrawals, & Safety Alerts. 3.Media coverage: Often, if a drug recall affects many people, or the recalled drug causes severe injury or death, the media will report on the recall.